Diplomat to Participate in Upcoming Investor Conferences
FLINT, Mich. — August 24, 2016 — Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation’s largest independent specialty pharmacy, has announced that Phil Hagerman, Chairman & CEO, and Sean Whelan, CFO, will present at four upcoming investor conferences.
Mr. Hagerman and Mr. Whelan are scheduled to participate in the Robert W. Baird 2016 Healthcare Conference in New York on Wednesday, September 7, 2016 at 10:50 AM ET.
Mr. Hagerman and Mr. Whelan are scheduled to participate in the Wells Fargo 2016 Healthcare Conference in Boston on Thursday, September 8, 2016 at 10:30 AM ET.
Mr. Hagerman and Mr. Whelan are scheduled to participate in the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 14, 2016 at 2:10 PM ET.
Mr. Hagerman and Mr. Whelan are scheduled to participate in the 7th Annual Credit Suisse Small/Mid Cap Conference in New York on Thursday, September 15, 2016 at 8:10 AM ET.
A live audio-only webcast of the Robert W. Baird 2016 Healthcare Conference presentation and related presentation materials will be available on the investor relations section of the Company’s website at ir.diplomat.is. The archived webcast and presentation materials will also be available for 90 days at the same URL.
To learn more about Diplomat, visit www.diplomat.is.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit diplomat.is.
Bob East, Westwicke Partners
443.213.0500 | firstname.lastname@example.org
Jenny Cretu, Diplomat
810.768.9370 | email@example.com
@DiplomatRx@JNJNews treatment Zytiga significantly cut the death risk for ... prostate cancer patients by 38% https://t.co/6Ga1okf4Ye @ASCO #ASCO174 days ago
@sloan_ketteringRT @sloan_kettering: Your immune system provides one of the best defenses against cancer. But sometimes it needs a little help. More about…1 week ago
@DiplomatRxThank you to @corpmagazine for recognizing Diplomat as a 2017 Michigan Economic Bright Spot awardee!2 weeks ago
@DiplomatRxFriend and Patient Advocate, Brenda Williams Hawkes was featured in @MyGoodDays Days this month!… https://t.co/TFGSoMecqO2 weeks ago
@DiplomatRxJeff Park Elected to Diplomat Board of Directors https://t.co/IMI1aRwNbm2 weeks ago